Weekly Recap | Vor BioPharma -10.98%, phase 3 enrolment completeWeekly Review·Sep 12 at 07:12 AMVOR-3.29%
The Nasdaq Biotechnology Index fell by more than 1%. Among the constituent stocks, Lyell Immunopharma dropped 11.28%, Vor Biopharma fell 8.16%, Alumis decreased 6.99%, and Oruka Therapeutics declined 7.93%. Meanwhile, Coherus BioSciences rose 6.34%, Pyxis Oncology increased 8.02%, Ultragenyx Pharmaceutical gained 13.59%, and Jyong Biotech surged 43.38%Wallstreetcn·Dec 30, 2025 at 07:31 PMLYEL-3.71%PYXS-2.92%
U.S. stock market midday update: Vor BioPharma up 12.73%Price Alert·Jul 28, 2025 at 02:03 PMVOR-3.29%
U.S. stock market quick update: Vor BioPharma down 10.13%Price Alert·Jul 16, 2025 at 03:48 PMVOR-3.29%
U.S. stock market update: Vor BioPharma down 8.26%Price Alert·Jul 10, 2025 at 03:22 PMVOR-3.29%BPMC0.00%
Pre-market hot trades in US stocks: Vor BioPharma up 7.87% in pre-marketPrice Alert·Jul 10, 2025 at 08:37 AMVOR-3.29%STKH-7.37%
U.S. Stock Market Midday Update: Vor BioPharma up 14.79%Price Alert·Jul 9, 2025 at 02:02 PMVOR-3.29%CLDI-4.10%
Pre-market hot trades in US stocks: Vor BioPharma up 7.50% in pre-marketPrice Alert·Jul 9, 2025 at 10:32 AMVOR-3.29%SCAG+6.36%
U.S. stock market update: Vor BioPharma down 7.49%Price Alert·Jul 8, 2025 at 03:52 PMVOR-3.29%MRNA-1.99%
Pre-market hot trades in US stocks: Wolfspeed up 10.82% in pre-market; Vor BioPharma up 10.49% in pre-marketPrice Alert·Jul 8, 2025 at 08:02 AMWOLF+0.25%VOR-3.29%
